AMP
46
-11
AMT
59
7
VMC
51
-14
NAVI
24
-9
CHD
56
3
GPC
45
-5
SIG
41
-16
MAT
33
-18
ADBE
40
-4
SWKS
31
-11
WDC
26
-10
OXY
33
-16
NTRS
25
-14
OKE
53
-20
MNST
54
-2
PH
52
-15
PPG
33
-8
IFF
35
-7
MTCH
30
-10
AEE
81
2
AMP
46
-11
AMT
59
7
VMC
51
-14
NAVI
24
-9
CHD
56
3
GPC
45
-5
SIG
41
-16
MAT
33
-18
ADBE
40
-4
SWKS
31
-11
WDC
26
-10
OXY
33
-16
NTRS
25
-14
OKE
53
-20
MNST
54
-2
PH
52
-15
PPG
33
-8
IFF
35
-7
MTCH
30
-10
AEE
81
2
Financhill
Back

scPharmaceuticals 10K Form

Sell
1

SCPH
scPharmaceuticals

Last Price:
$2.33
Seasonality Move:
-6.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-13 10Q SCPH/scPharmaceuticals Quarterly
2020-05-12 10Q SCPH/scPharmaceuticals Quarterly
2020-03-24 10K SCPH/scPharmaceuticals Annual
2019-11-12 10Q SCPH/scPharmaceuticals Quarterly
2019-08-07 10Q SCPH/scPharmaceuticals Quarterly
2019-05-08 10Q SCPH/scPharmaceuticals Quarterly

Receive SCPH News And Ratings

See the #1 stock for the next 7 days that we like better than SCPH

SCPH Financial Statistics

Sales & Book Value

Annual Sales: $36.3M
Cash Flow: $-15.2M
Price / Cash Flow: 0
Annual Sales: $0.27
Price / Book: 8.68

Profitability

EPS (TTM): -1.90000
Net Income (TTM): $-85.1M
Gross Margin: $25M
Return on Equity: -370.01%
Return on Assets: -90.4%

scPharmaceuticals Earnings Forecast

Key scPharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 3 years for SCPH is 68.73%.
  • The Selling, General & Administrative Expenses for SCPH have been equal to 213.72% of Gross Profit Margin.
  • The Research & Development expenses have been 33.30% of Revenue.
  • The Net Earning history of SCPH is -234.36% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 3 years.

scPharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SCPH
CUSIP: 810648
Website: scpharmaceuticals.com

Debt

Debt-to-Equity Ratio: 3.86
Current Ratio: 7.12
Quick Ratio: 5.87

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 9.65

SCPH Technical Analysis vs Fundamental Analysis

Sell
1
scPharmaceuticals (SCPH) is a Sell

Is scPharmaceuticals a Buy or a Sell?

  • scPharmaceuticals stock is rated a Sell
    The current scPharmaceuticals [SCPH] share price is $2.30. The Score for SCPH is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.